Authors: Paquette, LA Bibart, RT Seekamp, CK Kahane, AL

Citation: La. Paquette et al., Spirocyclic restriction of nucleosides. Synthesis of the first exemplary syn-1-oxaspiro[4.4]nonanyl member, ORG LETT, 3(25), 2001, pp. 4039-4041

Authors: Paquette, LA Owen, DR Bibart, RT Seekamp, CK

Citation: La. Paquette et al., Spirocyclic restriction of nucleosides. An analysis of protecting group feasibility while accessing prototype anti-1-oxaspiro[4.4]nonanyl mimics, ORG LETT, 3(25), 2001, pp. 4043-4045

Authors: Paquette, LA Lanter, JC Owen, DR Fabris, F Bibart, RT Alvarez, M

Citation: La. Paquette et al., Resolution and absolute configurational assignments to 1-oxa- and 1-thia-6-ketospiro[4.4]nonanyl platforms, HETEROCYCLE, 54(1), 2001, pp. 49-53

Authors: Fang, XG Bibart, RT Mayr, S Yin, W Harmon, PA McCafferty, JF Tyrrell, RJ Reed, RA

Citation: Xg. Fang et al., Purification and identification of an impurity in bulk hydrochlorothiazide, J PHARM SCI, 90(11), 2001, pp. 1800-1809

Authors: Paquette, LA Owen, DR Bibart, RT Seekamp, CK Kahane, AL Lanter, JC Corral, MA

Citation: La. Paquette et al., 1-oxaspiro[4.4]nonan-6-ones. Synthetic access via oxonium ion technology, optical resolution, and conversion into enantiopure spirocyclic alpha,beta-butenolides, J ORG CHEM, 66(8), 2001, pp. 2828-2834

Authors: Bibart, RT Vogel, KW Drueckhammer, DG

Citation: Rt. Bibart et al., Development of a second generation coenzyme A analogue synthon, J ORG CHEM, 64(8), 1999, pp. 2903-2909